To summarize, on one hand the modest upwards trajectory of the obese and diabetic population provides a fertile ground for Pharma companies to sell more for the years to come, however, downside risks remain, including: pricing, compounders and overall competition, which will make it hard for companies like Novo and Lilly to maintain their growth
However, in rare cases, the initial adjustment period during treatment may influence blood flow dynamics, a key factor in erectile function
Looking forward, enhancing the bioavailability and targeted delivery of polyphenols could open new avenues in drug development for metabolic disorders, dermatological applications, and the formation of functional foods aimed at improving physical performance and overall well-being
Learning its story is valuable for anyone who is serious about managing their weight